Chemocentryx Inc (CCXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -70,259 | -38,608 | -131,755 | -91,227 | -68,920 |
| Depreciation Amortization | 2,041 | 1,017 | 3,139 | 3,498 | 1,120 |
| Accounts receivable | -4,492 | -2,356 | -285 | -19,888 | -2 |
| Accounts payable and accrued liabilities | 846 | -1,329 | 2,610 | 68 | 2,636 |
| Other Working Capital | 31,216 | 35,553 | 16,371 | -3,925 | 9,663 |
| Other Operating Activity | 23,353 | 14,554 | 34,299 | 46,740 | 16,085 |
| Operating Cash Flow | $-17,295 | $8,831 | $-75,621 | $-64,734 | $-39,418 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -628 | -224 | -19,020 | -18,527 | -14,177 |
| Purchase Of Investment | -126,757 | -91,498 | -307,449 | -246,166 | -198,944 |
| Sale Of Investment | 134,128 | 70,385 | 418,688 | 393,453 | 299,555 |
| Investing Cash Flow | $6,743 | $-21,337 | $92,219 | $128,760 | $86,434 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -1,049 | -1,049 | N/A |
| Common Stock Issued | 8,096 | 6,231 | 7,405 | 3,725 | 3,165 |
| Other Financing Activity | -3,126 | -3,126 | -5,273 | -5,273 | -5,273 |
| Financing Cash Flow | $4,970 | $3,105 | $1,083 | $-2,597 | $-2,108 |
| Beginning Cash Position | 51,058 | 51,058 | 33,377 | 33,377 | 33,377 |
| End Cash Position | 45,476 | 41,657 | 51,058 | 94,806 | 78,285 |
| Net Cash Flow | $-5,582 | $-9,401 | $17,681 | $61,429 | $44,908 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,295 | 8,831 | -75,621 | -64,734 | -39,418 |
| Capital Expenditure | -628 | -224 | -19,020 | -18,527 | -14,177 |
| Free Cash Flow | -17,923 | 8,607 | -94,641 | -83,261 | -53,595 |